News

The new numbers will affect what some employers owe if employees apply, and get, federal premium subsidies.

Although more than one-third of self-funded employers now cover GLP-1 drugs for weight loss, 31% of this group are considering stopping coverage or are unsure about continuing coverage in the next 12 to 24 months.

The 5ForLife Balanced Fund, in collaboration with Income America, is designed to provide participants in MissionSquare’s 9,200 employer plans with lifetime income, beginning at age 65.

The firm sees the astonishingly high cost of "cellular, gene and RNA therapies" — high-tech treatments for conditions like sickle cell disease — as an emerging threat

Dealmaking increased employer plans' childbirth-related hospital bills 3.3% and physician services bills 15%.

The lawsuit said the union’s health plan allowed coverage of Xenical to treat obesity but not newer products such as Wegovy or Zepbound. Nevertheless, since 2018, Optum Rx charged the union health plan $4,381,075 for 3,732 claims for uncovered weight-loss drugs, the plaintiffs alleged.